Craig-Hallum raised the firm’s price target on Aspen Aerogels to $21 from $17 and keeps a Buy rating on the shares. The positive trends in Aspen Aerogels’ business were clearly illustrated in Q4 with revenues in line with its recent pre-announcement, including record overall revenue, and Energy Industrial +12% quarter-over-quarter despite being capacity constrained, the firm says.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on ASPN:
- Aspen Aerogels Projects Optimistic Financial Outlook for 2024
- Aspen Aerogels sees FY24 EPS under (30c), consensus (24c)
- Aspen Aerogels, Inc. Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Recent Business Highlights
- Aspen Aerogels reports Q4 EPS (1c), consensus (12c)
- Is ASPN a Buy, Before Earnings?